Bulldog,
It also "kinda" depends on what you paid for
Bulldog,
It also "kinda" depends on what you paid for the million shares. Others here that purchased shares a few years back bought at an extremely low cost basis.
For "some" of "those" people, they are wanting an insane ROI both in $ and % wise. They only invested $1000 to get a million dollars. As opposed to someone investing $100,000. And that's why they are as angry as a child that missed their nappy! They blame GC that their $1000 isn't a million yet! They're furious at GC because they picked the right Lottery Numbers but for the wrong drawing date!
But, turn that around and invest more cash, then percentage wise it won't be as "impressive" but your Return ($) will be huge.
And there you have the idiocy of some people's incessant yammering about a scary R/S.
Cheers
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A headquarters wall can say more about a company than another polished mission statement ever will. On November 17, 2026, GALLS® unveiled the National Law Enforcement Officer Hall of Fame Wall at its Lexington, Kentucky, corporate headquarters, displaying portraits of every past inductee into the National Law Enforcement Officer Hall of Fame. Recognition, made permanent...
Continue Reading
Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...
Continue Reading
A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...
Continue Reading
Unpacking the AvidXchange Turmoil Staring at the ticker tape feels like watching a drama unfold, and today it's all about AvidXchange Holdings, Inc. (NASDAQ: AVDX). Levi & Korsinsky, LLP has launched an investigation into the fairness of its acquisition, and let me tell you, when the suits start poking around, it means someone smells a rat. The deal in question? A buyout...
Continue Reading
A hundred grand aimed at better graft science is not pocket change, but it is not a finished clinical program either. That distinction matters with the Orthopaedic Research and Education Foundation's newly opened $185,000 grant cycle. This is targeted, early-to-midstream research support: the sort of money that can produce usable data, sharpen a clinical question, and...
Continue Reading
Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...
Continue Reading
A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....
Continue Reading
A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...
Continue Reading
Protein Markets Scramble: Chicken Production Climbs Here’s a tasty tidbit that might just have investors reeling: the USDA says chicken production will be cruising on the up, whereas beef is taking a bit of a backseat. Yep, the big birds are flying higher, and the cows, well, they're just mooing a little softer. And what's that mean for big players like Tyson...
Continue Reading
A Family Day Like No Other at the LA Auto Show Kicking into gear this November, the 2026 Los Angeles Auto Show puts the pedal to the metal for families seeking a full day of fun without breaking the bank. We're talking about 10 solid days where auto-mania meshes with interactive experiences, all nestled in the Los Angeles Convention Center. Whether you're a gearhead or a...
Continue Reading
Top 5 Most Recently Viewed Articles
Introducing AXIA Time's Exclusive Collection AXIA Time, the official timepiece of prominent college football events, is excited to unveil a special collaboration with Ryan Day. This partnership marks a notable celebration for Ohio State University's recent achievements, delivering unique limited-edition items that honor the history of its football program. Limited Edition...
Continue Reading
AstraZeneca's Gigantic Leap In the hustle of Wall Street's whirring machine, June 5, 2026, dawned with a palpable buzz. Why? AstraZeneca (NYSE:AZN) just pulled off the biggest market cap transfer in the New York Stock Exchange's epic 234-year saga. Now that's a splash, not just a ripple. It’s like watching a giant whale breach in an already crowded ocean. But what does...
Continue Reading
A Groundbreaking Visionary in Anatomy Passes The world has lost a pioneer in anatomical science. Dr. Gunther von Hagens, inventor of the groundbreaking technique known as Plastination and creator of the BODY WORLDS exhibitions, passed away on July 24, 2026, at the age of 81. His innovative work fundamentally changed the way we view and understand human anatomy. Not quite...
Continue Reading
Reviving Ambitions at the Yacht Club de Monaco The Yacht Club de Monaco recently held a significant event, the 17th Business Symposium – La Belle Classe Superyachts, in collaboration with UBS. This prestigious dinner debate has evolved into more than just a gathering; it has transformed into a critical platform where influential figures in the yachting industry share...
Continue Reading
Marex Group Plc Set to Release Q3 2024 Earnings Soon Marex Group plc (NASDAQ: MRX) has officially announced that it will be unveiling its third quarter results for the fiscal year 2024. This significant event is scheduled to take place before the market opens on an upcoming Thursday in November. Investors and analysts are eagerly anticipating this release, which will...
Continue Reading